CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $3,531,000 | -38.3% | 66,873 | -20.5% | 0.02% | -45.5% |
| Q4 2017 | $5,719,000 | +160.3% | 84,106 | +215.4% | 0.04% | +214.3% |
| Q3 2017 | $2,197,000 | -81.3% | 26,664 | -78.7% | 0.01% | -81.1% |
| Q2 2017 | $11,742,000 | +51.3% | 125,406 | +2.9% | 0.07% | +19.4% |
| Q1 2017 | $7,761,000 | +294.4% | 121,899 | +469.6% | 0.06% | +210.0% |
| Q3 2015 | $1,968,000 | +365.2% | 21,400 | +250.8% | 0.02% | +150.0% |
| Q1 2014 | $423,000 | -78.5% | 6,100 | -81.3% | 0.01% | -78.9% |
| Q4 2013 | $1,971,000 | – | 32,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |